# Pain Management After Adductor Canal Block for Total Knee Arthroplasty

> **NCT06086483** · PHASE4 · COMPLETED · sponsor: **Poznan University of Medical Sciences** · enrollment: 361 (actual)

## Conditions studied

- Knee Osteoarthritis
- Knee Arthritis
- Knee Arthropathy
- Knee Pain Chronic

## Interventions

- **DRUG:** Ropivacaine 0.2% Injectable Solution
- **DRUG:** 0.9%sodium chloride

## Key facts

- **NCT ID:** NCT06086483
- **Lead sponsor:** Poznan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-18
- **Primary completion:** 2022-07-20
- **Final completion:** 2023-08-24
- **Target enrollment:** 361 (ACTUAL)
- **Last updated:** 2023-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06086483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06086483, "Pain Management After Adductor Canal Block for Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06086483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*